Citius Pharmaceuticals, Inc. (CTXR): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2022-09-30, while the company's latest annual report covers the year ended 2025-09-30. Its later filings do not report this line under the concept TickerFacts maps.

$90.0K
Year ended 2022-09-30
0.0%
3-year compound annual growth
+12.5%
5-year compound annual growth
2017-09-30: $50.0K2018-09-30: $75.0K2019-09-30: $90.0K2020-09-30: $90.0K2021-09-30: $90.0K2022-09-30: $90.0K$90.0K
2017-09-30 Revenue (USD) 2022-09-30
Period endedRevenueChange YoYSource filing
2022-09-30$90.0K0.0%2022-12-22, From 2021-10-01
2021-09-30$90.0K0.0%2022-12-22, From 2020-10-01
2020-09-30$90.0K0.0%2021-12-15, From 2019-10-01
2019-09-30$90.0K+20.0%2020-12-16, From 2018-10-01
2018-09-30$75.0K+50.0%2019-12-16, From 2017-10-01
2017-09-30$50.0Kn/a2019-12-16, From 2016-10-01